Related references
Note: Only part of the references are listed.Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment Chemoprevention with Rapamycin, an mTOR Inhibitor and Anti-Aging Drug
Isabelle Mercier et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Higher Expression of Caveolin-1 Inhibits Human Small Cell Lung Cancer (SCLC) Apoptosis In Vitro
Xiaohan Yang et al.
CANCER INVESTIGATION (2012)
Involvement of the TGFβ pathway in the regulation of α5β1 integrins by caveolin-1 in human glioblastoma
Erika C. Cosset et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Effect of Cavtratin, a Caveolin-1 Scaffolding Domain Peptide, on Oligodendroglial Signaling Cascades
Matthias Schmitz et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis
Meng Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Temozolomide Modifies Caveolin-1 Expression in Experimental Malignant Gliomas In Vitro and In Vivo
Celine Bruyere et al.
TRANSLATIONAL ONCOLOGY (2011)
Pathologic Caveolin-1 Regulation of PTEN in Idiopathic Pulmonary Fibrosis
Hong Xia et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Caveolin-1 Regulating the Invasion and Expression of Matrix Metalloproteinase (MMPs) in Pancreatic Carcinoma Cells
Fei Han et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Caveolin-1 gene silencing promotes the activation of PI3K/AKT dependent on Erα36 and the transformation of MCF10ACE
Feng Shuang et al.
SCIENCE CHINA-LIFE SCIENCES (2010)
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
Jun Sunayama et al.
STEM CELLS (2010)
RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis
Juwon Park et al.
TUMOR BIOLOGY (2010)
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Jason T. Huse et al.
NATURE REVIEWS CANCER (2010)
Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways
Meng Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Caveolin-1 regulates glioblastoma aggressiveness through the control of α5β1 integrin expression and modulates glioblastoma responsiveness to SJ749, an α5β1 integrin antagonist
Sophie Martin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status
Valeria Barresi et al.
HUMAN PATHOLOGY (2009)
Caveolin 1 Expression Independently Predicts Shorter Survival in Oligodendrogliomas
Rebecca Senetta et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Caveolin-1 Acts as a Tumor Suppressor by Down-Regulating Epidermal Growth Factor Receptor-Mitogen-Activated Protein Kinase Signaling Pathway in Pancreatic Carcinoma Cell Lines
Fei Han et al.
PANCREAS (2009)
Urokinase expression by tumor suppressor protein p53 - A novel role in mRNA turnover
Praveenkumar Shetty et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Caveolae as organizers of pharmacologically relevant signal transduction molecules
Hemal H. Patel et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Caveolin-1 inhibits membrane-type 1 matrix metalloproteinase activity
Hye-Nan Kim et al.
BMB REPORTS (2008)
Caveolin-1 in tumor progression: the good, the bad and the ugly
Jacky G. Goetz et al.
CANCER AND METASTASIS REVIEWS (2008)
Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation - Implications for the response to hormonal therapy
Isabelle Mercier et al.
CANCER BIOLOGY & THERAPY (2008)
Basal and UV-induced MMP-1 expression are inhibited by p53 in human dermal fibroblasts
Sangmin Kim et al.
EXPERIMENTAL DERMATOLOGY (2008)
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
Chao-Chi Ho et al.
LUNG CANCER (2008)
The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification
Concha Lopez-Gines et al.
NEUROPATHOLOGY (2008)
Central nervous system tumors
Jan C. Buckner et al.
MAYO CLINIC PROCEEDINGS (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: Concrete premises for a new reliable diagnostic marker in gliomas
Paola Cassoni et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth
Michelle I. Lin et al.
CANCER RESEARCH (2007)
The blood-brain barrier and cancer:: Transporters, treatment, and Trojan horses
John F. Deeken et al.
CLINICAL CANCER RESEARCH (2007)
The multiple faces of caveolae
Robert G. Parton et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
PIK3CA alterations in primary (de novo) and secondary glioblastomas
Daisuke Kita et al.
ACTA NEUROPATHOLOGICA (2007)
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: Correlation with EGFR status, tumor grade, and survival
Masahiro Mizoguchi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin
Vicente A. Torres et al.
JOURNAL OF CELL SCIENCE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma
K Nakatani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Caveolin-1 in oncogenic transformation, cancer, and metastasis
TM Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae
A Abulrob et al.
ONCOGENE (2004)
Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo -: Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion
TM Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A role for caveolae in cell migration
A Navarro et al.
FASEB JOURNAL (2004)
Caveolae: anchored, multifunctional platforms in the lipid ocean
B van Deurs et al.
TRENDS IN CELL BIOLOGY (2003)
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
AW Cohen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins
J Jodoin et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Caveolae: From cell biology to animal physiology
B Razani et al.
PHARMACOLOGICAL REVIEWS (2002)
Caveolin-1 expression is maintained in rat and human astroglioma cell lines
PL Cameron et al.
GLIA (2002)
The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers
MA Forget et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
The cyclin D1 gene is transcriptionally repressed by caveolin-1
J Hulit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
